300497 富祥药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-2.899-11.665-7.774-5.0881.659
总资产报酬率 ROA (%)-1.398-5.817-4.065-2.9051.119
投入资产回报率 ROIC (%)-1.536-6.361-4.448-3.2371.256

边际利润分析
销售毛利率 (%)12.0489.66510.62718.03630.498
营业利润率 (%)-7.971-24.373-14.251-8.1323.988
息税前利润/营业总收入 (%)-4.515-22.247-12.878-8.6764.779
净利润/营业总收入 (%)-8.798-23.810-13.870-9.9672.766

收益指标分析
经营活动净收益/利润总额(%)150.82455.30670.590-16.215298.611
价值变动净收益/利润总额(%)1.5284.8476.64958.112-239.689
营业外收支净额/利润总额(%)0.5210.5171.6226.133-3.515

偿债能力分析
流动比率 (X)1.1451.0891.4601.7711.700
速动比率 (X)0.8400.8161.1221.3311.394
资产负债率 (%)51.14952.01748.73046.84337.773
带息债务/全部投入资本 (%)44.41944.98242.67539.99529.444
股东权益/带息债务 (%)119.099118.000130.932146.304235.205
股东权益/负债合计 (%)94.65292.395105.813113.123162.983
利息保障倍数 (X)-1.291-9.876-8.008673.8665.156

营运能力分析
应收账款周转天数 (天)93.47881.82663.29457.39454.792
存货周转天数 (天)165.013144.766123.665129.296127.566